4th Annual Operationalise: Early Access Programmes Summit Europe

Improving Global Access to Life Changing Therapeutics

When patients can’t afford to wait, Early Access, Managed Access, Expanded Access, and Compassionate Use programmes become a vital lifeline. With growing demand across rare diseases, oncology, and advanced therapies - and increasing expectations from regulators, physicians, and patients - the need to execute programmes effectively has never been greater.

This 4th Operationalise: Early Access Programmes Summit Europe brings together professionals responsible for planning and executing early access programmes to share practical, real-world solutions for overcoming operational, regulatory, and compliance challenges. Across three days, you’ll explore how leading organisations navigate:

• Launching and scaling EAPs across multiple regions
• Regulatory and compliance considerations for diverse markets
• Ensure uninterrupted access by optimising supply and logistics in complex programmes
• Harnessing real-world evidence to support regulatory and commercial decisions
• Aligning internal teams and preparing for seamless transitions to commercial launch

With 120+ senior leaders across Access, Clinical Operations, Medical Affairs, Regulatory, and Supply Chain sharing insights and case studies, this summit offers strategies and frameworks that are relevant for any professional involved in designing, managing, or supporting early access initiatives.